Therapeutics, Inc. (NASDAQ:APGE), has sold 15,000 shares of the company's common stock, according to a recent SEC filing. The biotech company, currently valued at $2.37 billion, has received a ...

If Trump’s tariffs take effect next month, consumers are unlikely to see price increases until the current inventory is sold, ...

With support from Brown economist Emily Oster, senior Benjamin Moshes and his brother developed a website that visualizes the ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Aside from its $4.7 billion homebuilding cash balance, it also has $2.9 billion available on its revolving credit facility (or $7.6 billion of total homebuilding liquidity) Given our long-term outlook ...

Tariffs help spur U.S. manufacturing by discouraging U.S. companies from importing goods made in countries with low ...

Walk into nearly any grocery store at the moment and the price for a dozen eggs may shock you – if any eggs are in stock at ...

Techopedia speaks to Schneider Electric about a future where AI cuts energy bills, optimizes electricity use, and helps homes ...

BlackRock, with over $11.6 trillion in assets under management, has expanded its stake in Michael Saylor’s rebranded company, ...

This isn’t just a pricing advantage — it’s a structural advantage. IBM isn’t trying to outspend OpenAI or Google LLC on ...

One of the key challenges for nonprofits transitioning to the E&S market is the lack of package insurance products.

In the preceding weeks, the Trump administration took significant steps to strengthen the U.S. economy with sweeping policy ...